Engitix
ID: 5963100Human extracellular matrix (ECM)-based discovery platform for the treatment of fibrosis and cancer
3
Funding Rounds
$85.4m
Money raised
Recent Funding Rounds
Overview
Human extracellular matrix (ECM)-based discovery platform for the treatment of fibrosis and cancer
- Website:
- Business model: B2B
- Headquarters: London
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Gi****** Ma*** |
|
- | |
| Ma***** Pi***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Engitix has raised a total of $85.4m in funding over 3 rounds.
Key Insights:
- Engitix Series A Round, January 2026: $25m
- Engitix Limited Series A round, January 2022: $54m
- Engitix Limited Series A round, November 2018: $6.4m
Industries
Engitix is active in the following industries: